Atlas Trials

Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients

Clinical trial NCT03117569 · COMPLETED

Trial details

NCT number
NCT03117569
Sponsor
Kirby Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2017-08-21
Primary completion
2018-12-19
Enrollment
380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.